|
⚲
|
| Keyboard |
| Skvarka Jan
✚
|
|
|---|---|
| CIK # | 0001838042 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001838042] | |
| 4 | [0001838042] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Zentalis Pharmaceuticals Inc | |
| Skvarka Jan | |
| Monte Rosa Therapeutics Inc | |
| Trillium Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2025-06-17 | Grant | 57,603 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2025-06-13 | Grant | 30,700 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2025-01-31 | Buy | 60,000 | $1.72 | 103,200 |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2024-06-21 | Grant | 41,581 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2024-06-12 | Grant | 22,100 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2023-09-11 | Sell | 5,000 | $25.05 | 125,250 |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2023-06-16 | Grant | 16,364 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2023-06-14 | Grant | 20,500 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Stock Option (Right to Buy) · derivative
|
2023-03-30 | Grant | 41,000 | $0.00 | |
|
Zentalis Pharmaceuticals Inc ZNTL
Common Stock
|
2022-09-09 | Grant | 36,606 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-11-17 | Disposed to issuer | 197,000 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-11-17 | Disposed to issuer | 1,162,500 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-11-17 | Disposed to issuer | 600,000 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-05-12 | Option exercise | 23,802 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Common Shares
|
2021-05-12 | Sell | 23,802 | $9.24 | 219,930 |
|
Trillium Therapeutics Inc TRIL
Common Shares
|
2021-05-12 | Option exercise | 23,802 | $0.31 | 7,379 |
|
Trillium Therapeutics Inc TRIL
Common Shares
|
2021-05-11 | Sell | 106,698 | $9.20 | 981,622 |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-05-11 | Option exercise | 87,500 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Stock Option (Right to Buy) · derivative
|
2021-05-11 | Option exercise | 19,198 | $0.00 | |
|
Trillium Therapeutics Inc TRIL
Common Shares
|
2021-05-11 | Option exercise | 19,198 | $0.31 | 5,951 |
| showing 20 of 27 most recent transactions | |||||